KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: Kazia paxilisib in Dana Farber study enrols first patient, page-37

  1. 908 Posts.
    lightbulb Created with Sketch. 101
    FDA approval for aducanumab demonstrates that they will push drugs through approval earlier than the "experts" expect.
    JG has already indicated his confidence, and said that they are working on commercialisation.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.